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There has been significant interest in recent
years in the health experience ofagricultural
workers. Blair et al. (1) recently published a
meta-analysis of epidemiologic studies of
farmers and concluded that farmers have
significantly elevated rates of lip cancer,
Hodgkin's disease, melanoma, multiple
myeloma, stomach cancer, prostate cancer,
and leukemia. From these findings, they
inferred a possible role for pesticides (i.e.,
herbicides or insecticides) and other work-
related exposures. A major prospective
study has been initiated to evaluate risk fac-
tors for cancers and nonmalignant diseases
for farmers, their families, and for commer-
cial pesticide applicators (2).
Fundamental characteristics of agricul-
tural practice make it difficult to assess
potential health effects ofspecific pesticides.
The type, amount, and frequency of pesti-
cide use depends on a number of factors
including the crop, the level and severity of
pest infestation, weather conditions, recom-
mended usage, time ofyear, availability, and
cost. Preemergent herbicides, for example,
are used by farmers and pesticide applicators
only in the days or weeks before planting.
Such an occupational exposure scenario is
different from the chronic exposure scenario
typical of manufacturing environments.
Another complicating factor is that farmers
and pesticide applicators frequently use a
large number of different pesticides each
year, making it difficult to evaluate a single
orpredominant exposure scenario.
The primary advantage of studying
pesticide users is the large number ofsub-
jects available to be studied. However, in
light of the complications mentioned
above, such studies should be supplement-
ed by research on pesticide manufacturing
populations. Although manufacturing pop-
ulations tend to be relatively small, they
frequently have chronic exposure to specif-
ic pesticides and have worked under condi-
tions where exposures have been character-
ized or can be fairlywell documented.
We initiated a study of mortality and
cancer incidence among workers involved
in the manufacture of alachlor [2-chloro-
2',6'-diethyl-N-(methoxymethyl) -
acetanilide], the active ingredient in a fam-
ily of preemergent herbicides. Monsanto
has manufactured alachlor since March
1968 at a plant in Muscatine, Iowa.
Registration and domestic use of alachlor
began in the 1969 growing season. Since
that time, alachlor has been used widely on
corn, soybeans, and other crops.
Numerous experimental studies have
been conducted to characterize alachlor
metabolism and toxicology. Chronic feed-
ing studies at high doses found increased
frequencies of nasal, stomach, and thyroid
tumors in laboratory rats (3,4). The lowest
observed effect levels (LOELs) were 126
mg/kg daily for thyroid cancers and 42
mg/kg daily for thyroid tumors (exposure
levels that were overtly toxic to rats) and
15 mg/kg daily for nasal cancers.
Experimental evidence suggests that the
alachlor-related stomach and thyroid
tumors result from nongenotoxic mecha-
nisms at exposures that exceeded tolerable
doses (4,5). These mechanisms are not
operative in rats at lower doses.
Mechanistic research on the rat nasal
tumors points to a specific alachlor metabo-
lite (2,6-diethylbenzoquinoneimine) that
concentrates in rat nasal tissues (6).
Enzymatic capabilities of rat nasal cells to
produce this putative carcinogenic metabo-
lite exceed the capabilities of human nasal
cells by three to four orders of magnitude
(7). Whole-body autoradiographic studies
have shown accumulation of radiolabeled
alachlor or its metabolites in nasal tissues of
rats, but not in monkeys (7). It has been
estimated that the nasal tumor LOEL
exceeds manufacturing exposures in the
early years ofproduction by at least 40-fold
and typical current agricultural exposures
by25,000-fold (8).
An alachlor chronic feeding study in
mice found a statistically significant
increase in lung tumors among females in
the highest daily exposure group (260
mg/kg) (5). Lung tumor incidence for this
exposure group, however, was within the
range ofhistorical control values. A second
chronic study in mice did not show any
dose-related increase in lung tumors (9).
Metabolic studies in monkeys, used to
provide a surrogate model for human
metabolism, show that oral and dermal
alachlor exposures are metabolized and
excreted largely through the urinary tract,
with a small portion excreted through the
large bowel (10,11). Alachlor and fecal and
urinary metabolites of alachlor are negative
in Ames tests (12).
Previous studies of alachlor workers
from the Muscatine plant have considered
ocular effects, mortality for the period
1968-1990, and cancer incidence for the
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period 1970-1990 (8,13,14). The present
study updates mortality and cancer inci-
dence analyses through 1993 and provides
additional analyses ofworkplace and envi-
ronmental exposures not addressed in the
previous studies.
Methods
The total Muscatine plant population was
enumerated from Social Security
Administration (SSA) Quarterly Reports
on Earnings (form 941A). Demographic
and work history information was abstract-
ed from company employment records.
The mortality cohort was restricted to the
1199 workers employed at least 1 year
from plant start up as an ammonia facility
in 1961 through 31 December 1993.
The cancer incidence cohort was a sub-
set ofthe mortality cohort, including 1169
workers who lived in Iowa for some time
during the period 1969-1993. Thirty
employees from the mortality cohort were
excluded because they either lived nearby in
Illinois or transferred to another Monsanto
location before 1969. The criterion ofIowa
residence reflects the catchment area for the
State Health Registry of Iowa (SHRI),
which was the source for identifying cancers
in this study. The SHRI is a statewide, pop-
ulation-based cancer registry that has been
operating since 1969 and has participated
since 1973 in the National Cancer
Institute's Surveillance Epidemiology and
End Results Program.
Vital status was determined for the
mortality cohort until the end of 1993
using a variety of sources, including com-
pany payroll, pension and mortality files,
SSA (a submission prior to 1987 when SSA
stopped doing mortality searches for
researchers), the National Death Index, the
Iowa state motor vehicle bureau, and a
retail credit agency. In addition, direct trac-
ing by mail and phone was conducted as
part of the cancer incidence evaluation. As
a result ofthese procedures, 1166 (97.3%)
workers were found to be alive, 30 (2.5%)
were deceased, and 2 (0.2%) were lost to
follow-up. The proportions alive, deceased,
and lost to follow-up were similar for the
1036 workers judged to have had alachlor
exposure (see Table 1).
Death certificates were obtained for all
known decedents. Two nosologists inde-
pendently coded the underlying cause of
death (UCOD) for each decedent accord-
ing to the eighth revision of the
International Classification of Diseases
(15). The UCOD from each nosologist was
compared for each decedent and the single
disagreement, which involved the coding of
an accidental death into different subcate-
gories, was resolved by mutual agreement.
The incidence study cohort was
matched against the SHRI master database
to identify workers diagnosed with invasive
cancer from 1969 through 1993. Cancer
cases were identified based on the corre-
spondence between workers' identifying
information (social security numbers, full
names, and birth dates) in company files
and in SHRI's database. All inexact match-
es were verified by matching other data in
the workers' personnel files and in SHRI's
records. Incident cancer cases were coded
according to the second edition of the
International Classification of Diseases for
Oncology (16). SHRI was also the source
for general population Iowa cancer inci-
dence rates, which were used as a basis of
comparison for workers' cancer incidence
rates.
The major methodologic issue for con-
ducting a valid cancer incidence analysis
was correctly enumerating person-years at
risk within SHRI's catchment area. We
used a number ofdata linkage and tracing
procedures to address this issue. First, cur-
rent addresses were obtained from compa-
ny records for active workers and vested
former employees (i.e., workers employed
long enough to qualify for retirement bene-
fits). Current Iowa residents who lived in
Iowa or moved to Iowa when hired at the
Muscatine plant were assumed to have
lived in Iowa since their plant hire date.
Former vested employees who had a cur-
rent address outside ofIowa (mainly trans-
ferees within Monsanto) were assumed to
have been Iowa residents from their start
date at the Muscatine plant until their
transfer or employment termination date.
Present workers with a non-Iowa current
address and workers who terminated
employment before becoming vested were
sent a letter to establish their dates ofIowa
residency. We also matched these workers
with the Iowa Department of Motor
Vehicles, the company mortality database,
and databases maintained by a credit search
firm to establish possible Iowa residency
after employment termination. Finally, we
traced workers whose residence histories
remained unknown through directory assis-
tance and did a phone survey to identify as
many residence histories as possible. As a
result ofthese tracing procedures, residence
historywas determined for 98.4% ofwork-
ers with potential alachlor exposure as of
31 December 1993 (Table 1). Follow-up
improved with length of potential expo-
sure: we determined residence history for
all but 2 of 481 employees who had 5 or
more years of alachlor exposure. These 2
employees became lost to follow-up 2 years
and 1 month, respectively, before the end
ofstudydate.
Another methodologic issue concerns
cancer incidence of workers who left the
SHRI catchment area and were excluded
from the cancer incidence analyses as ofthe
date they left. Workers who remained in
Iowa had more than twice as many years of
alachlor exposure than workers who left
Iowa, so migration is not likely to affect the
validity of our results. Cancer risk was also
assessed through national mortalityanalyses.
ExposureAssessment
There was insufficient information on
plant conditions to estimate alachlor expo-
sures quantitatively during the study peri-
od. Therefore, our exposure estimation was
qualitative, based on work history informa-
tion, judgment of an industrial hygienist,
and, to a lesser extent, recent exposure
monitoring data (17).
The first step in the exposure estimat-
ing process was the creation of a depart-
ment/job title dictionary that included all
work locations and job assignments in
Table 1. Distribution ofworkers bygender, alachlor exposure status, and follow-up status
Group Men Women Total
Mortality cohort
Total 954 245 1199
Nonwhites (excluded from analysis) 20 6 26
Nonalachlor (excluded from analysis) 93 44 137
Alachlor-exposed 841 195 1036
No. alive 817 191 1008 (97.3%)
No. dead 23 4 27 (2.6%)
No. losttofollow-up 1 0 1( 0.1%)
Incidence cohort
Total 928 241 1169
Nonwhites (excluded from analysis) 20 6 26
Nonalachlor (excluded from analysis) 77 41 118
Alachlor-exposed 831 194 1025
No. in lowa through 1993 573 142 715(69.8%)
No. migrated from Iowa before 1993 228 43 271 (26.4%)
No. unknown migration date from Iowa 12 4 16(1.6%)
Incident cancers 19 5 24a
aOne worker had two incident cancers.
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workers' personnel records. Jobs with simi-
lar exposure potential were consolidated by
the plant industrial hygienist into occupa-
tional exposure categories (OEC). The
plant hygienist then assigned each OEC a
high, medium, low, or negligible qualita-
tive exposure ranking for alachlor as well as
for other specific chemicals. The exposure
rankings considered changes in exposure
potential over time resulting from changes
in plant technology as documented by
standard manufacturing process reports,
industrial hygiene and safety reports, a 25-
year chronology of the plant's history, and
interviews with long-term employees.
The qualitative exposure rankings were
based primarily on the opportunity for der-
mal contact with alachlor. Inhalation expo-
sures were judged to be an extremely minor
component of total exposure due to
alachlor's extremely low vapor pressure (1.6
x 10-5 mm Hg at 25°C). Current and his-
torical airborne measurements relative to
alachlor vapor have averaged less than 10
ppb. The more recent granular and water
dispersible alachlor formulations create the
possibility of airborne exposure via dusts,
but even in these operations airborne mea-
surements have averaged much less than
100 parts per billion.
The qualitative exposure rankings did
not discriminate between daily and inter-
mittent exposures for workers with differ-
ent jobs in the same department/location.
Thus, for a given department/location,
production and maintenance workers had
the same exposure ranking. However, pro-
duction workers, particularly those in for-
mulation and packaging operations, had
more frequent potential for (dermal)
alachlor exposure than maintenance work-
ers, except perhaps for the initial year(s) of
the alachlor process when exposures were
more similar for these two groups.
A source ofexposure ofuncertain mag-
nitude and duration was contamination of
the plant drinking water. The contamina-
tion was discovered incidentally in June
1975. While developing a method for mea-
suring alachlor concentrations in water, a
"control" sample from the plant's drinking
water showed an alachlor concentration of
2 mg/l (2 ppm). Plant management imme-
diately notified workers and brought in
bottled drinking water to eliminate expo-
sure. Soon thereafter the plant's water sup-
plywas switched to other wells at the plant.
Subsequent alachlor measurements from
the new wells averaged 8 pg/l (8 ppb)
through 1980. At that time, installation of
a carbon filtration system was completed,
which reduced alachlor in the water supply
to below the minimum detection level of
0.03 ag/l.
Workers' exposure to alachlor from
drinking water would depend on the dura-
tion of the water contamination at the
plant and the amount of water consumed
on a daily basis. Both aspects of exposure
were unknown to us. However, if we
assume a constant well water concentration
of 2 mg/l and that workers drank 1 1 of
plant water daily, we estimate that exposure
from drinking water would equal that in
high-exposure jobs.
In certain analyses we classified all
workers employed from 1968 to 1975 in
the high-exposure category (to allow for
the maximum possible period of drinking
water contamination), even if their jobs
entailed no occupational exposure. We also
conducted analyses based on various more
restrictive periods ofdrinking water conta-
mination to assess the potential impact of
misclassification based on drinking water
exposure.
We conducted analyses based only on
occupational exposures. A relatively small
number of workers had exposure only via
drinking water, and excluding these work-
ers from the analysis of alachlor-exposed
workers did not appreciably affect the
results.
EpidemiologicAnalysis
The epidemiologic measures of effect for
the mortality and incidence analyses were
the standardized mortality and incidence
ratios (SMR, SIR). These measures were
expressed as the ratio ofobserved to expect-
ed events and are equivalent to the ratio of
disease rates for workers and the general
population adjusted for age, gender, and
calendar period. The numbers of expected
deaths or incident cases were calculated by
summing the product of the number of
employee person-years, stratified by age,
calendar period, and gender, and rates for
the corresponding groups in the Iowa gen-
eral population. The Occupational Cohort
Mortality Analysis Program was used to
conduct the SMR and SIR analyses (18).
The 95% CI was calculated as a measure of
the statistical variability of the SMR or
SIR. Approximate CI calculations were
employed when the number of observed
deaths exceeded five; Fisher exact CIs were
calculated in the other instances (15)).
Enumeration of person-years for the
mortality and cancer incidence analyses
began 1 year after first employment, in
light of the 1 year employment eligibility
criterion for cohort enumeration, or on the
date offirst alachlor exposure, iflater.
For the mortality analysis, person-years
were accumulated through the end ofstudy
date for employees found to be alive, until
date lost to follow-up, or until date of
death for deceased employees. For the can-
cer incidence analysis, person-years were
accumulated until the end of the study
period for employees who were alive and
residing in Iowa at the end of study date,
until date ofdeath for employees who died
in Iowa during the study period, until date
of migration from Iowa, until date of last
contact (usually employment termination
date) for employees with unknown resi-
dence histories, or until cancer diagnosis
date for incident cases.
SMRs and SIRs were evaluated for
workers by the number ofyears ofalachlor
exposure and by time since first exposure.
We dichotomized the analyses at 5 or more
years of exposure and at 15 or more years
since first exposure, which divided expect-
ed numbers approximately evenly on each
dimension.
We excluded 26 non-whites from the
analyses due to their small numbers. There
were no incident cancer cases among these
workers (0.1 expected) and all were alive as
ofthe end ofstudy date. We also excluded
employees who did not work in alachlor
departments and who were not employed
at the plant during the 1968-1975 and
1976-1980 drinking water contamination
periods. The major non-alachlor depart-
ments included ammonia production and
storage before 1968, and acrylonitrile-buta-
diene-styrene plastics production after
1975.
Results
Mortality
A total of 1036 workers met the criteria for
inclusion in the mortality analysis and had
potential alachlor exposure in manufactur-
ing jobs or via drinking water. Mortality
from all causes combined for these workers
was lower than Iowa rates for both the total
cohort (27 observed, SMR = 0.7, 95% CI,
0.4-1.0) and for those with 5 or more years
exposure and 15 years since first exposure
(4 observed, SMR = 0.4, 95% CI, 0.1-0.9).
Mortality from cancer was similar to Iowa
rates (Table 2; 8 observed, SMR = 0.9,
95% CI, 0.4-1.7), and there were slight to
moderate deficits of cancer mortality for
workers with 5 or more years ofexposure (3
observed, SMR = 0.6, 95% CI, 0.1-1.8)
and 15 or more years since first exposure (1
observed, SMR = 0.2, 95% CI, 0-1.1).
Results were similar for workers with high
alachlor exposure (Table 2).
SMRs for specific cancers, heart disease,
and accidents are given in Table 3 for
workers with high alachlor exposure. There
were no deaths due to stomach, thyroid,
and nasal cancer (the three tumors
observed in the chronic feeding studies of
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laboratory rats) versus the small expected
values. The six observed cancer deaths were
distributed among six different cancer sites,
and there were no noteworthy findings for
specific cancers. Ischemic heart disease
mortality was somewhat less than expected.
Mortality from accidents was similar to
Iowa rates for the total highly exposed sub-
group and for those with 5 or more years of
exposure and 15 or more years since first
exposure.
Cancer Incidence
A total of 1025 white males and females
met the criteria for the cancer incidence
analyses and were estimated to have poten-
tial exposure to alachlor either in their jobs
or via drinking water. Linkage with SHRI
identified 37 cancers during the study peri-
od, 13 of which were in situ carcinomas,
mostly cervical (n = 9) and skin (n = 2),
and 24 were invasive cancers in 23 individ-
uals. In situ cancers were not included in
our analyses because SHRI incidence rates
are routinely based on invasive cancers
(with the exception of bladder cancer) and
because population-based ascertainment of
in situ cancers is questionable, especially for
the cervix and skin melanoma.
Over the 1969-1993 study period, can-
cer incidence was slighdyhigher for alachlor
workers than for the Iowa general popula-
tion (24 observed, SIR = 1.4, 95% CI,
0.9-2.1; Table 4). SIRs were similarly ele-
vated for workers during active employ-
ment (14 observed, 11.1 expected, SIR =
1.3, 95% CI, 0.7-2.1) and after employ-
ment termination (10 observed, 6.0 expect-
ed, SIR = 1.7, 95% CI, 0.8-3.0), suggest-
ing that employment status was not a factor
affecting cancer ascertainment. The cancer
SIR varied by duration of exposure and
time since first exposure (Table 4). The SIR
was elevated for workers with less than 5
years ofemployment and less than 15 years
since first exposure (10 observed, SIR = 1.9,
95% CI, 0.9-3.6). The 10 cancers were var-
ied and included 1 salivary gland, 1 rectum,
1 female breast, 1 cervix, 1 uterus, 1 testis, 1
melanoma, 2 Hodgkin's disease, and 1
chronic myeloid leukemia (CML). Workers
with 5 or more years of exposure (13
observed, SIR = 1.3, 95% CI, 0.7-2.2) and
workers with 15 or more years since first
exposure (9 observed, SIR = 1.2, 95% CI,
0.6-2.3) had cancer incidence similar to
expected values. During the 1991-1993
update period, there were 6 observed and
5.3 expected cancers (SIR = 1.1, 95% CI,
0.4-2.5).
Of the 1025 alachlor workers, 701
(68%) were classified as having the poten-
tial for high exposures. These high expo-
sures included occupational exposures and
Table 2. Standardized mortality ratios (SMRs) for all cancerfor employees with potential alachlor expo-
sure (workplace and drinking water)
Duration of exposure/
time since first exposure No. ofworkersa Person-yearsa O/E deathsb SMR 95% Cl
All alachlor exposed workers
<5years/<15 years 1,036 8,774 4/2.6 1.5 0.4-3.9
<5years/15+ years 336 1,687 1/1.8 0.6 0-3.1
5+years/<15 years 485 4,452 3/1.9 1.6 0.3-4.7
5+ years/15+ years 434 2,488 0/3.0 0 0-1.3
Total 1,036 17,400 8/9.3 0.9 0.4-1.7
Workers with high alachlor exposure
<5 years/<15 years 708 8,249 3/2.7 1.1 0.2-3.3
<5years/15+ years 520 2,565 1/2.3 0.4 0-2.4
5+years/< 15years 159 1,553 2/0.8 2.5 0.3-9.0
5+years/15+ years 160 1,445 0/2.3 0 0-1.6
Total 708 13,812 6/8.1 0.7 0.3-1.6
8Number ofworkers not mutually exclusive across groups, though person-years are.
bObserved number of deaths/expected number of deaths.
Table 3. Standardized mortality ratios (SMRs) forvarious causes of death for employees with potential
high alachlor exposure (workplace and drinking water)a
5+ years exposure; 15+ years
Totalb since firstexposurec
Cause of death (ICD 8) O/Ed SMR 95% Cl O/E SMR 95% Cl
All causes (0-999) 23/34.4 0.7 0.4-1.0 4/7.6 0.5 0.1-1.4
All cancers (140-209) 6/8.1 0.7 0.3-1.6 0/2.3 0 0-1.6
Stomach cancer(151) 0/0.2 0/0.1
Thyroid cancer(193) 0/0.04 0/0.01
Lung cancer(162) 1/2.3 0.4 0-2.4 0/0.8
Colorectal cancer(153,154) 0/0.8 0/0.3
Breast cancer(174) 0/0.3 0/0.1
Prostate cancer(185) 0/0.2 0/0.1
Kidney cancer(189) 0/0.2 0/0.1
Leukemia (204-207) 1/0.4 - 0/0.1
Brain cancer (191, 192) 0/0.6 0/0.1
Hodgkin's disease (201) 0/0.2 - 0/0.02
Melanoma (172) 0/0.3 0/0.1
Ischemic heartdisease (410-3) 4/7.1 0.6 0.2-1.4 1/2.1 0.5 0-2.6
Accidents (800-949) 8/7.2 1.1 0.5-2.2 0/0.6
aSIRs and 95% Cis were not calculated unlessthere were at leasttwo observed or expected deaths.
b708workers, 13,811 person years.
C160workers, 1,652 person years.
dObserved number of cases/expected number of cases.
Table 4. Standardized incidence ratios (SIRs) for all cancerfor employees with potential alachlor expo-
sure (workplace and drinking water)
Duration of exposure/
time since first exposure No. ofworkersa Person-yearsa O/Eb SIR 95% Cl
All alachlor-exposed workers
<5years/<15 years 1,024c 6,585 10/5.2 1.9 0.9-3.6
<5years/15+ years 193 871 1/1.9 0.5 0-3.0
5+years/<15 years 481 4,122 5/4.6 1.1 0.3-2.5
5+years/15+ years 383 2,076 8/5.5 1.5 0.6-2.9
Total 1,025 13,654 24/17.1 1.4 0.9-2.1
Workers with high alachlor exposure
<5years/<15 years 700d 6,787 6/5.8 1.0 0.4-2.3
<5years/15+ years 387 1,676 5/3.3 1.5 0.5-3.5
5+years/<15 years 159 1,455 3/1.7 1.8 0.4-5.3
5+years/15+ years 138 1,179 4/3.8 1.0 0.3-2.7
Total 701 11,097 18/14.6 1.2 0.7-2.0
aNo. ofworkers notmutually exclusive across groups,though person-years are.
bObserved number of cases/expected number of cases.
cOne worker moved into the Iowa study area after achieving either 5 years of exposure or 15 years since
first exposure.
dTwo workers moved into the Iowa study area after achieving either 5 years of high exposure or 15 years
since firsthigh exposure.
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presumed drinking water exposures during
the 1968-1975 period. Cancer incidence
was fairly similar for these workers and the
Iowa population (18 observed, SIR = 1.2,
95% CI, 0.7-2.0) (Table 4). Analyses that
considered only 1974-1975 as the period
of drinking water exposure gave similar
results (17 observed, SIR = 1.3, 95% CI,
0.8-2.1). Workers exposed 5 or more years
with at least 15 years since first exposure
had 4 observed and 3.8 expected cancers
(SIR = 1.0, 95% CI, 0.3-2.7).
Results for specific cancers for workers
with high exposure showed no observed
cases or 1 case for most sites and elevated
SIRs for colorectal cancer, chronic myeloid
leukemia (CML), Hodgkin's disease, and
melanoma based on 3, 2, 2, and 2 cases,
respectively (Table 5). One of the CML
cases was diagnosed soon after first employ-
ment at the plant, which, given the course
of CML, indicates etiologic factors before
employment at the plant. Among workers
with 5 or more years of exposure, there
were no cases of CML or Hodgkin's dis-
ease, 1 case of melanoma (0.2 expected),
and 2 colorectal cancer cases (SIR 3.9, 95%
CI, 0.5-14.2). The results were similar for
all alachlor-exposed workers.
We did a further analysis ofcancer inci-
dence focusing on 429 alachlor production
workers. Our definition of production
workers allowed for a maximum of90 days
in maintenance jobs. Many of these work-
ers were employed in formulation and
packaging operations, where there was
potential for high dermal exposure on a
daily basis during the earlyyears ofproduc-
tion. Among workers with less than 5 years
exposure, there were 7 observed versus 4.5
expected cancers (SIR = 1.6, 95% CI,
0.6-3.2), while for workers with 5 or more
years exposure, there were 2 observed ver-
sus 2.2 expected cancers (SIR = 0.9, 95%
CI, 0.1-3.3). Overall, there were no
observed cases of colorectal cancer versus
0.6 expected, 1 case of CML versus 0.1
expected, and no cases of malignant
melanoma versus 0.6 expected.
Discussion
The purpose of this study was to monitor
patterns of cancer mortality and incidence
for alachlor workers, especially for cancer
sites seen in chronic feeding studies ofrats,
and to follow-up on the slight colorectal
cancer excess seen in the previous incidence
study (14). We did not see a relationship
between cancer incidence and years of
alachlor exposure or time since first expo-
sure, and there were no cancers ofthe thy-
roid, stomach, or nose and nasal sinuses
among exposed workers. The numbers of
observed and expected cases were small for
Table 5. Standardized incidence ratios (SlRs)forvarious cancers for employees with potential high
alachlor exposure (work place and drinking water)a
5+ years exposure; 15+ years
Totalb since firstexposurec
Cancer site/type (ICD-0-2 codes) OlEd SIR 95% Cl O/E SIR 95% Cl
All cancers 18/14.6 1.2 0.7-1.9 4/3.8 1.0 0.3-2.7
Lung (C339-49) 1/1.9 1/0.8 -
Colorectal 3/1.6 1.9 0.4-5.6 2/0.6 3.9 0.5-14.2
(C180-9,C260,C199,C209,C210-8)
Breast(C500-9) 1/1.2 - 0/0.2
Prostate (C619) 0/0.7 0/0.3 -
Kidney(C649) 0/0.5 - - 0/0.2
Bladder (C670-679) 0/0.7 - 0/0.2
Hodgkin'sdisease(M9650-9667) 1/0.5 - - 0/0.04
Non-Hodgkin's lymphoma 2/0.8 2.4 0.3-8.8 0/0.2
(M9590-5,M9670-9714)
Chronic myeloid leukemia (M9863,M9868) 210.1 18.6 2.3-67.2 0/0.02
Other leukemias 0/0.4 0/0.1
(M9800-9941, excluding M9863,9868)
Testes (C620-29) 1/0.8 - - 0/0.1 -
Melanoma (C440-9, M8720-90 only) 2/1.1 1.9 0.2-6.7 1/0.2
aSIRs and 95% Cls were not calculated unlessthere were at leasttwo observed or expected cases.
b701 workers, 11,097 person years.
C138workers, 1,179 person years.
dObserved number ofcases/expected number of cases.
most cancer sites, which makes the SMRs
and SIRs imprecise and precludes informa-
tive exposure-response analyses for individ-
ual cancer sites.
There were no new colorectal cancer
cases during the update period versus 0.6
expected, lessening the observed/expected
ratio previously reported (14). This obser-
vation, in conjunction with the lack ofany
cases among workers in formulation and
packaging and the minor involvement of
the large bowel in alachlor metabolism and
excretion, tends to support a noncausal
interpretation ofthe colorectal cancer find-
ings for this cohort. Further follow-up of
these workers will be important to monitor
incidence from colorectal and other cancers.
The major limitation of this study is
the small numbers ofincident cancers and
cancer deaths. The cohort is still relatively
young (74% ofperson years under observa-
tion were less than 40 years ofage), and the
follow-up period is relatively short. In
terms of power, the study had more than
80% power to detect a relative risk of 2.0
for all cancers, but the power for major
individual cancer sites would exceed 80%
only for relative risks of5 or higher (20).
A second limitation is the possibility of
exposure misclassification due to the diffi-
culty in estimating dermal occupational
exposures, for which there is no accepted
methodology even today, and exposures
from plant drinking water. Exposure esti-
mation, however, is more straightforward
for these workers than for agricultural pop-
ulations because the plant manufacturing
history is well documented, there is a long
standing industrial hygiene program, and
work history records documenting depart-
mental assignments and workers' jobs were
fairly complete.
Despite the limitations of this study,
the findings are useful for assessing poten-
tial alachlor-related health risks. The expo-
sure circumstances for this manufacturing
cohort are unique among alachlor-exposed
workers, the vast majority of whom are
involved in agricultural applications for a
few days or weeks each year. It has been
estimated that the relatively high daily
exposures characteristic of early manufac-
turing operations exceed exposures in agri-
culture by several orders ofmagnitude (8).
Ifthis is true, then this study has exposure
weighted years ofobservation equivalent to
an extremely large study of agricultural
workers. Periodic follow-ups ofthis cohort,
in conjunction with an on-going, large,
prospective study of farmers and applica-
tors (2, should provide the most compre-
hensive assessment possible of potential
health risks for workers with various levels
of alachlor exposure. At present, however,
the available data from manufacturing
workers do not indicate an appreciable haz-
ard during the study period related to
alachlor exposure.
REFERENCES
1. Blair A, Hoar-Zahm S, Pearce NE, Heineman
EF, Fraumeni JF Jr. Clues to cancer etiology
from studies offarmers. Scand J Work Environ
Health 18:209-215 (1992).
2. Alavanja MC, Akland G, Baird D, Blair A,
Bond A, Dosemeci M,. Kamel F. Lewis R,
Lubin J, Lynch C. Cancer and noncancer risk
to women in agriculture and pest control: the
732 Volume 104, Number 7, July 1996 * EnvironmentalHealth PerspectivesArticles - Mortality and cancer among alachlor workers
agricultural health study. J Occup Med
36:1247-1250 (1994).
3. Daly I, Hogan G. A chronic feeding study of
alachlor in rats. Monsanto report no. BDN-77-
421. St. Louis, MO:Monsanto Company,
1991.
4. Stout LD. Chronic study of alachlor in rats
investigating the ocular lesions. Monsanto
Environmental Health Laboratory study no.
ML-80-224. St. Louis, MO:Monsanto
Company, 1984.
5. Daly I, Hogan G. An eighteen month chronic
feeding study of alachlor in mice. Monsanto
report no. BDN-77-423. St. Louis,
MO:Monsanto Company, 1981.
6. Wilson AG, Hall LJ. Application of whole-
body autoradiography in toxicology testing.
Toxicol Meth 1:147-160 (1991).
7. Asbury KJ, Lau HHW, Hopkins WE, Wilson
AGE. In vitro metabolism of alachlor, 2,6-
diethyl-2-methylthioacetanilide (alachlor sec-
ondary sulfide), alachlor sec-amide, and 2,6-
diethylaniline by rat and human nasal
turbinates and liver. Monsanto Environmental
Health Laboratory study no. ML-93-14. St.
Louis, MO:Monsanto Company, 1993.
8. Acquavella JF, Ireland BK, Leet T, Anne M,
Farrell TF, Martens M. Epidemiologic studies
of morbidity and mortality among alachlor
manufacturing workers. In: Proceedings of the
XII Joint CIGR, IAAMRH, IUFRO
International Symposium: Health, safety and
ergonomic aspects in use of chemicals in agri-
culture and forestry, 8-11 June 1993. Kiev,
Ukraine:Institute for Occupational Health,
1994;184-194.
9. Roloff MV, Thake DC, Heydens WF.
Oncogenicity study ofalachlor administered in
feed to CD-1 mice for 18 months. Monsanto
report no. MSL-13847. St. Louis, MO:Mon-
santo Company, 1994.
10. Hopkins WE, Logusch SJ, Solsten RT, Wilson
AGE. Metabolism study ofalachlor in the rhe-
sus monkey following oral administration. Part
II: identification, characterization, and quanti-
tation of alachlor and its metabolites.
Monsanto report no. MSL-14128. St. Louis,
MO:Monsanto Company, 1995.
11. Johnson DE. Percutaneous absorption study of
Lasso MCB/C9 in Rhesus monkeys. Monsanto
report no. IR-84-246. St. Louis, MO:Mon-
santo Company, 1984.
12. Kier LD. Ames/Salmonella mutagenicity assays
of bile from Long-Evans rats treated with
alachlor. Monsanto report no. MSL-4878, St.
Louis, MO:Monsanto Company, 1985.
13. Ireland BK, Acquavella JF, Anne M, Farrell T,
Fuhreman T. Evaluation of ocular effects
among alachlor manufacturing workers. J
Occup Med 36:738-742 (1994).
14. Leet T, Acquavella JF, Lynch CF, Anne M,
Weiss N, Vaughn T, Checkoway H. Cancer
incidence among alachlor manufacturing work-
ers. AmJ Ind Med (in press).
15. U.S. DHEW. Eighth revision international
classification of diseases adapted for use in the
United States. DHEW publication no. 1693.
Washington, DC:Public Health Service, 1968.
16. WHO. International classification of diseases
adapted for oncology. 2nd ed. Geneva:World
Health Organization, 1990.
17. Anne M. Exposure estimation report for the
Muscatine plant. Internal report. Muscatine,
IA:Monsanto Company, 1992.
18. Marsh GM, Preninger ME. OCMAP: a user-
oriented occupational cohort mortality analysis
program. Am Stat 34:245-246 (1980).
19. Rothman KJ, Boice J. Epidemiologic analysis
with a programmable calculator. NIH publica-
tion no. 79-1649. Washington, DC:U.S.
Government Printing Office, 1979.
20. Breslow NE, Day NE. Statistical methods in
cancer research, vol 2. The design and analysis
of cohort studies. IARC scientific publications
no. 82. Lyon:International Agency for Research
on Cancer, 1987.
Seventh
North American
ISSX( Meeting
October 20-24, 1996
The Seventh North American Meeting ofthe International Society for the Study of Xenobiotics (ISSX)
will take place in San Diego, California from October 20-24, 1996 at the historic Hotel del Coronado.
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Scientific Program
Scientific Program will highlight these themes:
Enzymology of xenobiotic biotransformation Enzyme induction
FMO and P450 Drug development and safety evaluation
Hydrolytic enzymes Environmental and agricultural chemicals
Conjugating enzymes Cosmetic and food chemicals
Human drug metabolism and polymorphisms Biotechnology products
In vitro test systems and methodologies Regulatory affairs
For more information:
ISSX, PO Box 3, Cabin John, MD 20818 USA
FAX: 301-983-5357
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